Thalassemia Knowledge in Young People of Indonesia

Sponsor
Fakultas Kedokteran Universitas Indonesia (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT04706585
Collaborator
(none)
1,010
1
4.3
234.7

Study Details

Study Description

Brief Summary

There is still an ongoing lack of awareness about thalassemia among Indonesians despite high disease prevalence, and this is associated with poor implementation of preventive and promotive measures. Thalassemia experts argue that education and raising awareness about thalassemia must be done from an early age in order to relieve the heavy disease burden of thalassemia, especially in Indonesia as it is geographically located in the thalassemia belt. In spite of this, there has been limited research on public perception towards thalassemia in Indonesia, particularly among young people.

In this study, the researcher will ask young people in Indonesia between the age of 15-24 who are currently attending high school or university-level education to fill in an online survey. The survey consists of questions about the participants' demographic information as well as their knowledge, attitude, and practice (KAP) scores towards thalassemia. The study is expected to run from December 2020 to March 2021, with the online survey distributed in January 2021. Data collection will immediately follow, and it will be analyzed using univariate, bivariate, and multivariate analysis using the appropriate statistical tests. The findings gathered from this study will be vital in providing new insight into how the youth sees thalassemia in Indonesia. Such public health information will prove to be important in designing successful thalassemia intervention and education programs for Indonesian youth.

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    Research concept

    In this study, the researcher will ask young people in Indonesia between the age of 15-24 who are currently attending high school or university-level education to fill in an online survey. The survey consists of questions about the participants' demographic information as well as their knowledge, attitude, and practice (KAP) scores towards thalassemia. The study is expected to run from December 2020 to March 2021, with the online survey distributed in January 2021. Data collection will immediately follow, and it will be analysed using univariate, bivariate, and multivariate analysis using the appropriate statistical tests.

    Study design

    To evaluate the knowledge, attitude, and practice of Indonesian youth, the study design used will be observational, cross-sectional. An online questionnaire developed by the research team along with several experts is expected to be disseminated to the target population in January 2021. In light of the ongoing pandemic, this is expected to be a nationwide study where most of the work is done via online methods.

    Place and period of study

    This study will be conducted via online survey due to the ongoing pandemic situation. The study is expected to run from December 2020 to March 2021.

    Study Design

    Study Type:
    Observational
    Anticipated Enrollment :
    1010 participants
    Observational Model:
    Ecologic or Community
    Time Perspective:
    Cross-Sectional
    Official Title:
    Thalassemia in Indonesia: Current Knowledge, Attitude, and Practice Among Young People
    Anticipated Study Start Date :
    Jun 1, 2021
    Anticipated Primary Completion Date :
    Jul 1, 2021
    Anticipated Study Completion Date :
    Oct 10, 2021

    Arms and Interventions

    Arm Intervention/Treatment
    Youth

    Young people in Indonesia between the age of 15-24 who are currently attending high school or university-level education to fill in our online survey.

    Outcome Measures

    Primary Outcome Measures

    1. Indonesian youth's level of knowledge on thalassemia [Baseline, pre-intervention]

      To determine the relationships among Indonesian youth's demographic, education and socioeconomic level to their knowledge of thalassemia via a validated self-developed questionnaire. Knowledge will be assessed through question of common knowledges surrounding thalassemia, a final score (out of 100) will be used as representation of knowledge level (0-25: poor, 25-50 moderate, 51-75 good, and 76-100 very good) will be evaluated after participants answer all the questions.

    2. Indonesian youth's attitude towards thalassemia [Baseline, pre-intervention]

      To determine the relationships among Indonesian youth's demographic, education and socioeconomic level to their attitude towards thalassemia via a validated self-developed questionnaire. (using a Likert scale of 1 to 4 - with 1 being "strongly agree" and 4 "strongly disagree")

    3. Indonesian youth's practice towards thalassemia [Baseline, pre-intervention]

      To determine the relationships among Indonesian youth's demographic, education and socioeconomic level to their action and practice towards prevention of thalassemia via a validated self-developed questionnaire. (using a Likert scale of 1 to 4 - with 1 being "strongly agree" and 4 "strongly disagree")

    Secondary Outcome Measures

    1. Willingness to undergo thalassemia screening [Baseline, pre-intervention]

      To determine Indonesian youth's willingness (using a Likert scale of 1 to 4 - with 1 being "strongly agree" and 4 "strongly disagree") to undergo thalassemia screening independently

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    15 Years to 24 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • Survey participants are based in Indonesia

    • Survey participants are between the age of 15-24 and currently attending high school or university level education

    • Survey participants include both thalassemia-affected patients and non-patients

    • Survey participants have understood and given their consent for the research

    Exclusion Criteria:
    • Currently not studying/living in Indonesia

    • Below the age of 15 or above 24

    • No consent is given

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Fakultas Kedokteran Universitas Indonesia - Rumah Sakit Cipto Mangunkusumo Jakarta Pusat DKI Jakarta Indonesia 10430

    Sponsors and Collaborators

    • Fakultas Kedokteran Universitas Indonesia

    Investigators

    • Principal Investigator: Pustika A Wahidiyat, Professor., Fakultas Kedokteran Universitas Indonesia
    • Principal Investigator: Mikhael Yosia, Dr., Fakultas Kedokteran Universitas Indonesia
    • Study Director: Edward C Yo, Fakultas Kedokteran Universitas Indonesia
    • Study Chair: Muhammad M Wildani, Fakultas Kedokteran Universitas Indonesia
    • Study Chair: Visabella R Triatmono, Fakultas Kedokteran Universitas Indonesia

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    Responsible Party:
    Fakultas Kedokteran Universitas Indonesia
    ClinicalTrials.gov Identifier:
    NCT04706585
    Other Study ID Numbers:
    • MHS001
    First Posted:
    Jan 13, 2021
    Last Update Posted:
    May 11, 2021
    Last Verified:
    May 1, 2021
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Fakultas Kedokteran Universitas Indonesia
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of May 11, 2021